Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-13 Sale |
2025-01-14 4:10 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
1,599 | $28.7 | $45,895 | 58,796 (Direct) |
View |
| 2025-01-13 Sale |
2025-01-14 4:09 pm |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
783 | $28.7 | $22,474 | 37,358 (Direct) |
View |
| 2025-01-06 Sale |
2025-01-08 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer |
2,816 | $33.81 | $95,215 | 55,560 (Direct) |
View |
| 2024-12-23 Sale |
2024-12-27 4:06 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
63 | $33.09 | $2,085 | 57,145 (Direct) |
View |
| 2024-12-11 Sale |
2024-12-13 4:15 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
5,000 | $34.23 | $171,175 | 192,857 (Indirect Direct) |
View |
| 2024-09-16 Sale |
2024-09-17 5:21 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
37,000 | $36.23 | $1,340,597 | 247,526 (Indirect Direct) |
View |
| 2024-09-16 Sale |
2024-09-17 4:08 pm |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
192 | $36.21 | $6,952 | 38,141 (Direct) |
View |
| 2024-09-03 Sale |
2024-09-04 4:07 pm |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
550 | $39.49 | $21,720 | 38,333 (Direct) |
View |
| 2024-06-21 Sale |
2024-06-21 7:34 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
37,000 | $39.24 | $1,451,835 | 302,371 (Indirect Direct) |
View |
| 2024-05-08 Sale |
2024-05-09 5:15 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
78,907 | $42.35 | $3,341,848 | 1,224,605 (Direct) |
View |
| 2024-04-08 Sale |
2024-04-09 4:25 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
69,107 | $54.17 | $3,743,605 | 1,153,263 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-02 4:06 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
4,000 | $58.66 | $234,640 | 407,473 (Indirect Direct) |
View |
| 2024-03-19 Sale |
2024-03-20 5:18 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
18,681 | $57.18 | $1,068,161 | 337,871 (Indirect Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
9,913 | $56.9 | $564,050 | 54,693 (Direct) |
View |
| 2024-03-15 Sale |
2024-03-18 4:19 pm |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
184 | $56.46 | $10,389 | 38,883 (Direct) |
View |
| 2024-03-13 Sale |
2024-03-14 4:17 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
11,220 | $57.56 | $645,838 | 56,287 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-11 4:08 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
69,107 | $62.19 | $4,297,549 | 1,222,370 (Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 4:07 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
250,000 | $64.11 | $16,028,706 | 2,219,608 (Indirect Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 4:04 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
6,000 | $63.22 | $379,340 | 411,473 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 5:06 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
781 | $67.77 | $52,926 | 194,095 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 5:05 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
1,148 | $67.77 | $77,796 | 92,453 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:59 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
1,431 | $67.77 | $96,974 | 149,570 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:49 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
3,962 | $67.77 | $268,492 | 2,035,230 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-08 Option Award |
2025-01-10 5:39 pm |
N/A 2032-01-08 |
Apellis Pharmaceuticals Inc. | APLS | Walbert Keli Director |
15,388 | $33 | 24,478 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 5:39 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Walbert Keli Director |
9,090 | $0 | 24,478 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 4:25 pm |
N/A 2032-12-31 |
Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director |
17,466 | $0 | 28,904 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 4:23 pm |
N/A 2032-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
17,466 | $0 | 800,177 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 4:19 pm |
N/A 2032-12-31 |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
17,466 | $0 | 33,904 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 4:17 pm |
N/A 2032-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
17,466 | $0 | 269,592 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 4:12 pm |
N/A 2032-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Chan Gerald Director |
17,466 | $0 | 28,904 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 4:09 pm |
N/A 2028-02-15 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
11,096 | $0 | 269,570 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 4:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
10,054 | $13.85 | 269,570 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 4:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
1,042 | $14.95 | 269,570 (Direct) |
View |
| 2024-11-01 Other |
2024-11-01 6:43 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
182,146 | $0 | 2,035,230 (Indirect) |
View |
| 2024-09-27 Gift |
2024-09-30 4:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
10,569 | $0 | 197,857 (Indirect) |
View |
| 2024-09-23 Exercise |
2024-09-24 4:20 pm |
N/A 2028-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
4,600 | $0 | 252,126 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-24 4:20 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
4,600 | $13.19 | 252,126 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-13 4:13 pm |
N/A 2029-02-27 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
5,201 | $0 | 75,194 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-13 4:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
5,201 | $13.85 | 75,194 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-01 4:02 pm |
N/A 2028-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
900 | $0 | 307,871 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-01 4:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
900 | $13.19 | 307,871 (Direct) |
View |
| 2024-05-20 Exercise |
2024-05-21 4:03 pm |
N/A 2026-02-06 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
24,500 | $0 | 1,153,263 (Direct) |
View |
| 2024-05-20 Exercise |
2024-05-21 4:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
24,500 | $3.76 | 1,153,263 (Direct) |
View |
| 2024-05-08 Exercise |
2024-05-09 5:15 pm |
N/A 2027-08-22 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
78,907 | $0 | 1,224,605 (Direct) |
View |
| 2024-05-08 Exercise |
2024-05-09 5:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
78,907 | $4.31 | 1,224,605 (Direct) |
View |
| 2024-04-18 Gift |
2024-04-19 7:27 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
14,164 | $0 | 149,570 (Direct) |
View |
| 2024-04-12 Exercise |
2024-04-15 4:09 pm |
N/A 2028-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
1,500 | $0 | 344,871 (Direct) |
View |
| 2024-04-12 Exercise |
2024-04-15 4:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
1,500 | $13.19 | 344,871 (Direct) |
View |
| 2024-04-08 Exercise |
2024-04-09 4:25 pm |
N/A 2026-02-07 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
69,107 | $0 | 1,153,263 (Direct) |
View |
| 2024-04-08 Exercise |
2024-04-09 4:25 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
69,107 | $3.76 | 1,153,263 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-02 4:06 pm |
N/A 2027-10-18 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
4,000 | $0 | 407,473 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-02 4:06 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
4,000 | $10.03 | 407,473 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-11 4:08 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
69,107 | $3.67 | 1,222,370 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-11 4:08 pm |
N/A 2026-02-07 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
69,107 | $0 | 1,222,370 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 07:45 am |
N/A 2029-02-07 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
3,762 | $0 | 197,857 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 07:45 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
3,762 | $13.85 | 197,857 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:07 pm |
N/A 2026-02-06 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
250,000 | $0 | 2,219,608 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:07 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
200,000 | $4.31 | 2,219,608 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:07 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
50,000 | $3.76 | 2,219,608 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:04 pm |
N/A 2027-10-18 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
6,000 | $0 | 411,473 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
6,000 | $10.03 | 411,473 (Direct) |
View |